Online citations, reference lists, and bibliographies.

Effects Of Neuroprotectants Before And After Stroke: Statins And Anti-hypertensives

R. Villa, F. Ferrari, A. Moretti
Published 2017 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Neuroprotection, as an anjunct or alternative therapy to thrombolysis, may be a rational strategy to improve penumbra survival. Nevertheless, so far none of the neuroprotectants found active in preclinical studies have been translated into clinical use.
This paper references
10.1016/J.ATHEROSCLEROSISSUP.2004.08.026
The discovery and development of HMG-CoA reductase inhibitors.
A. Endo (1992)
10.1177/1470320315583582
Cerebroprotective effects of RAS inhibitors: Beyond their cardio-renal actions
Jaspreet Kalra (2015)
10.1038/jcbfm.2011.110
α2-Adrenoceptors do not Mediate Neuroprotection in Acute Ischemic Stroke in Mice
M. Brede (2011)
10.1016/j.ejphar.2013.12.003
Pharmacological modulation of I(1)-imidazoline and α2-adrenoceptors in sub acute brain ischemia induced vascular dementia.
S. Gupta (2014)
10.1161/CIRCULATIONAHA.104.516757
Multitargeted Effects of Statin-Enhanced Thrombolytic Therapy for Stroke With Recombinant Human Tissue-Type Plasminogen Activator in the Rat
L. Zhang (2005)
10.1159/000319067
Relative Contribution of Lipids and Apolipoproteins to Incident Coronary Heart Disease and Ischemic Stroke: The PRIME Study
F. Canouï-Poitrine (2010)
10.1016/j.jstrokecerebrovasdis.2008.09.016
Statins in ischemic stroke: just low-density lipoprotein lowering or more?
L. Stead (2009)
10.1111/bph.12770
Angiotensin‐(1–7) induces cerebral ischaemic tolerance by promoting brain angiogenesis in a Mas/eNOS‐dependent pathway
Teng Jiang (2014)
10.1016/j.jacc.2009.07.062
Cholesterol-lowering interventions and stroke: insights from a meta-analysis of randomized controlled trials.
R. De Caterina (2010)
10.1161/01.STR.0000169920.64180.fa
Familial Hypercholesterolemia Patients Treated With Statins at No Increased Risk for Intracranial Vascular Lesions Despite Increased Cholesterol Burden and Extracranial Atherosclerosis
S. Soljanlahti (2005)
10.1111/ijs.12477
Effects of Candesartan in Acute Stroke on Vascular Events during Long-Term Follow-up: Results from the Scandinavian Candesartan Acute Stroke Trial (SCAST)
A. G. Hornslien (2015)
10.1212/WNL.0b013e318281cc83
The THRombolysis and STatins (THRaST) study
M. Cappellari (2013)
10.1056/NEJM200001203420301
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.
S. Yusuf (2000)
10.1161/01.ATV.18.5.738
Esterified cholesterol accumulation induced by aggregated LDL uptake in human vascular smooth muscle cells is reduced by HMG-CoA reductase inhibitors.
V. Llorente-Cortés (1998)
10.1161/01.STR.15.3.486
Treatment of acute focal cerebral ischemia with propranolol.
J. R. Little (1984)
10.1212/01.wnl.0000346751.39886.01
HEMORRHAGIC STROKE IN THE STROKE PREVENTION BY AGGRESSIVE REDUCTION IN CHOLESTEROL LEVELS STUDY
M. Goldstein (2009)
10.1016/j.npep.2013.09.002
The expression of angiotensin-converting enzyme 2–angiotensin-(1–7)–Mas receptor axis are upregulated after acute cerebral ischemic stroke in rats
J. Lu (2013)
10.1161/CIRCULATIONAHA.111.055269
Statins and Intracerebral Hemorrhage: Collaborative Systematic Review and Meta-Analysis
D. Hackam (2011)
Effects of amlodipine and enalapril on platelet function in patients with mild to moderate hypertension.
R. Hernández-Hernández (1999)
10.1093/aje/kwr362
Use of calcium channel blockers and Parkinson's disease.
B. Pasternak (2012)
10.1016/j.amjmed.2015.02.008
Apparent Treatment-resistant Hypertension Among Individuals with History of Stroke or Transient Ischemic Attack.
V. Howard (2015)
10.1586/erc.09.106
Statins and stroke prevention
M. Paciaroni (2009)
10.1213/00000539-199110000-00016
Clonidine Decreases Plasma Catecholamines and Improves Outcome From Incomplete Ischemia in the Rat
W. Hoffman (1991)
10.1517/17425255.2015.1056149
Drug–drug interactions that interfere with statin metabolism
T. Hirota (2015)
10.1016/j.brainres.2010.05.035
Simvastatin improves clinical scores in a rabbit multiple infarct ischemic stroke model: Synergism with a ROCK inhibitor but not the thrombolytic tissue plasminogen activator
P. Lapchak (2010)
10.1016/J.ATHEROSCLEROSIS.2007.07.033
High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic review.
P. Amarenco (2008)
10.1097/01.WCB.0000130867.32663.90
Bumetanide Inhibition of the Blood-Brain Barrier Na-K-Cl Cotransporter Reduces Edema Formation in the Rat Middle Cerebral Artery Occlusion Model of Stroke
M. O'Donnell (2004)
10.1111/j.1471-4159.2012.07773.x
Evidence for the efficacy of statins in animal stroke models: a meta‐analysis
L. García-Bonilla (2012)
10.1016/j.atherosclerosis.2014.10.098
Renin inhibition reduces atherosclerotic plaque neovessel formation and regresses advanced atherosclerotic plaques.
H. Wu (2014)
10.1161/STROKEAHA.111.633354
High-dose statins should be used in all acute ischemic strokes.
Majaz Moonis (2012)
10.1161/STR.0000000000000046
Guidelines for the Primary Prevention of Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
J. Meschia (2014)
10.1016/j.ebiom.2015.08.006
The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Open-label, Parallel-group Study
N. Hosomi (2015)
Effect of prior medical treatments on ischemic stroke severity and outcome.
S. Sacco (2011)
10.1523/JNEUROSCI.2544-04.2005
3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors Attenuate β-Amyloid-Induced Microglial Inflammatory Responses
Andrew Cordle (2005)
10.1161/STROKEAHA.113.002751
Dose-Related Effects of Statins on Symptomatic Intracerebral Hemorrhage and Outcome After Thrombolysis for Ischemic Stroke
J. Scheitz (2014)
10.1016/j.ijcard.2010.06.005
Effects of clinical and laboratory variables and of pretreatment with cardiovascular drugs in acute ischaemic stroke: a retrospective chart review from the GIFA study.
A. Tuttolomondo (2011)
10.1111/j.1751-7176.2011.00530.x
PROGRESS: Prevention of Recurrent Stroke
H. Arima (2011)
10.1101/GAD.11.18.2295
Rho GTPases and signaling networks.
L. Van Aelst (1997)
10.2174/1567205011666141001114858
The complex actions of statins in brain and their relevance for Alzheimer's disease treatment: an analytical review.
Aydé Mendoza-Oliva (2014)
10.6091/ibj.13672.2014
Candesartan Attenuates Ischemic Brain Edema and Protects the Blood–Brain Barrier Integrity from Ischemia/Reperfusion Injury in Rats
H. Panahpour (2014)
10.1038/jcbfm.1983.4
Nimodipine Improves Cerebral Blood Flow and Neurologic Recovery after Complete Cerebral Ischemia in the Dog
P. Steen (1983)
10.1161/STROKEAHA.115.010319
Effects of Blood Pressure and Blood Pressure–Lowering Treatment During the First 24 Hours Among Patients in the Third International Stroke Trial of Thrombolytic Treatment for Acute Ischemic Stroke
E. Berge (2015)
10.1038/hr.2009.179
Azelnidipine, a long-acting calcium channel blocker, could control hypertension without decreasing cerebral blood flow in post-ischemic stroke patients. A 123I-IMP SPECT follow-up study
M. Watanabe (2010)
10.1016/j.phrs.2010.12.007
Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action.
E. Barone (2011)
Bumetanide protects focal cerebral ischemia-reperfusion injury in rat.
G. Wang (2014)
10.1536/JHJ.45.977
The effects of atorvastatin treatment on the fibrinolytic system in dyslipidemic patients.
C. Orem (2004)
10.1111/ene.12472
Orolingual angioedema after alteplase therapy of acute ischaemic stroke: incidence and risk of prior angiotensin‐converting enzyme inhibitor use
Sy Lin (2014)
10.1016/j.pharmthera.2015.06.004
Pharmacological therapy of acute ischaemic stroke: Achievements and problems.
A. Moretti (2015)
10.1097/JNN.0000000000000170
Time to Blood Pressure Control Before Thrombolytic Therapy in Patients With Acute Ischemic Stroke: Comparison of Labetalol, Nicardipine, and Hydralazine
Courtney McKay (2015)
10.1517/14740338.2012.712959
Statin drug interactions and related adverse reactions
S. Bellosta (2012)
10.1161/STROKEAHA.111.646778
Total and High-Density Lipoprotein Cholesterol and Stroke Risk
Y. Zhang (2012)
10.1016/j.ejphar.2015.01.037
Levosimendan alone and in combination with valsartan prevents stroke in Dahl salt-sensitive rats.
Jouko Levijoki (2015)
10.1007/s11883-015-0520-y
Timing of Blood Pressure Lowering in Acute Ischemic Stroke
C. Carcel (2015)
10.1161/01.STR.31.6.1250
Effect of intravenous nimodipine on blood pressure and outcome after acute stroke.
N. Ahmed (2000)
10.1016/j.jns.2011.05.026
Does statin in the acute phase of ischemic stroke improve outcome after intravenous thrombolysis? A retrospective study
M. Cappellari (2011)
10.2174/1570159X12666140923210929
The Many Roles of Statins in Ischemic Stroke
J. Zhao (2014)
10.2174/1570159X11311020007
ACE2-Ang-(1-7)-Mas Axis in Brain: A Potential Target for Prevention and Treatment of Ischemic Stroke
Teng Jiang (2013)
10.1038/jcbfm.2009.105
Atorvastatin Extends the Therapeutic Window for tPA to 6 h after the Onset of Embolic Stroke in Rats
L. Zhang (2009)
10.1111/ijs.12085
Comparison between Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on the Risk of Stroke Recurrence and Longitudinal Progression of White Matter Lesions and Silent Brain Infarcts on MRI (CEREBRAL Study): Rationale, Design, and Methodology
Shigeru Yamano (2015)
10.1038/sj.jcbfm.9600006
Na+-Dependent Chloride Transporter (NKCC1)-Null Mice Exhibit Less Gray and White Matter Damage after Focal Cerebral Ischemia
H. Chen (2005)
10.1034/j.1600-079X.2002.02900.x
Effect of melatonin and nifedipine on some antioxidant enzymes and different energy fuels in the blood and brain of global ischemic rats
H. El-Abhar (2002)
10.2174/138920112798868737
Statins in the treatment of acute ischemic stroke.
F. Montecucco (2012)
10.1161/STROKEAHA.111.627729
Statin Use During Ischemic Stroke Hospitalization Is Strongly Associated With Improved Poststroke Survival
A. Flint (2012)
10.1113/expphysiol.2011.058578
Cerebroprotection by angiotensin‐(1–7) in endothelin‐1‐induced ischaemic stroke
A. P. Mecca (2011)
10.1056/NEJMoa0801317
Telmisartan, ramipril, or both in patients at high risk for vascular events.
S. Yusuf (2008)
10.1159/000207444
Pre-Stroke Use of Antihypertensives, Antiplatelets, or Statins and Early Ischemic Stroke Outcomes
A. Yu (2009)
Isolated systolic hypertension in the elderly : implications of SHEP for clinical practice and for the ongoing trials
J. Staessen (1991)
10.1161/STROKEAHA.110.602615
Risk and Cumulative Risk of Stroke Recurrence: A Systematic Review and Meta-Analysis
K. M. Mohan (2011)
10.1212/01.wnl.0000264931.34941.f0
Statin enhancement of collateralization in acute stroke
B. Ovbiagele (2007)
10.1016/0896-6273(88)90162-6
Glutamate neurotoxicity and diseases of the nervous system
D. Choi (1988)
10.1046/J.1523-1755.2000.00160.X
Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo1
S. Nakamura (2000)
10.1161/STR.0000000000000024
Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.
W. Kernan (2014)
10.1007/s00415-011-6137-3
Statin pretreatment may increase the risk of symptomatic intracranial haemorrhage in thrombolysis for ischemic stroke: results from a case–control study and a meta-analysis
S. Martínez-Ramírez (2011)
10.1023/A:1007568811691
Inhibitory Potencies of 1,4-dihydropyridine Calcium Antagonists to P-glycoprotein-Mediated Transport: Comparison with the Effects on CYP3A4
M. Katoh (2004)
10.1161/HYPERTENSIONAHA.107.089763
Prevention of Stroke and Myocardial Infarction by Amlodipine and Angiotensin Receptor Blockers: A Quantitative Overview
J. Wang (2007)
10.1291/hypres.31.2147
Hemodynamic Influences of Azelnidipine, a Novel Calcium Channel Blocker, on Cerebral Circulation in Hypertensive Patients with Ischemic White Matter Lesions
Y. Kimura (2008)
10.1097/01.hjh.0000194120.42722.ac
The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients
L. Liu (2005)
10.1212/WNL.0b013e318270400b
Outcomes after thrombolysis in AIS according to prior statin use
E. Meseguer (2012)
10.1111/j.1524-6175.2003.02521.x
The ANBP2 and ALLHAT: Conflicting or Consistent?
J. Cutler (2003)
10.1016/j.neuint.2013.10.004
Energy metabolism of cerebral mitochondria during aging, ischemia and post-ischemic recovery assessed by functional proteomics of enzymes
R. Villa (2013)
10.1016/S0014-2999(98)00774-2
Ca2+ channel antagonists and neuroprotection from cerebral ischemia.
T. Kobayashi (1998)
Frequency and Temporal Profile of Poststroke Hyperglycemia Using Continuous Glucose Monitoring
Louise Allport (2006)
10.1002/glia.22974
Simvastatin and atorvastatin facilitates amyloid β‐protein degradation in extracellular spaces by increasing neprilysin secretion from astrocytes through activation of MAPK/Erk1/2 pathways
N. Yamamoto (2016)
10.1186/2040-7378-4-16
Neuroprotective effect of an angiotensin receptor type 2 agonist following cerebral ischemia in vitro and in vivo
Seyoung Lee (2012)
10.1161/STROKEAHA.115.010244
Safety of Statin Pretreatment in Intravenous Thrombolysis for Acute Ischemic Stroke
G. Tsivgoulis (2015)
10.1007/s00228-015-2001-1
Relationship between pre-stroke cardiovascular medication use and stroke severity
S. Desmaele (2015)
10.2174/157016111106140128113121
Risk and benefit of statins in stroke secondary prevention.
P. Laloux (2013)
10.1212/01.WNL.0000058840.66596.1A
Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke
M. Hill (2003)
10.1001/jama.2009.1619
Major lipids, apolipoproteins, and risk of vascular disease.
E. Di Angelantonio (2009)
10.1016/j.atherosclerosis.2015.08.043
Comparative effects of more versus less aggressive treatment with statins on the long-term outcome of patients with acute ischemic stroke.
Konstantinos Tziomalos (2015)
10.1016/j.bbi.2014.05.015
Differential effects of sympathetic nervous system and hypothalamic–pituitary–adrenal axis on systemic immune cells after severe experimental stroke
Eva Mracskó (2014)
10.1161/CIRCULATIONAHA.113.004243
C-Reactive Protein, but not Low-Density Lipoprotein Cholesterol Levels, Associate With Coronary Atheroma Regression and Cardiovascular Events After Maximally Intensive Statin Therapy
R. Puri (2013)
10.1007/s12975-015-0419-5
Critical Early Thrombolytic and Endovascular Reperfusion Therapy for Acute Ischemic Stroke Victims: a Call for Adjunct Neuroprotection
P. Lapchak (2015)
Progress in understanding the LDL receptor and HMG-CoA reductase, two membrane proteins that regulate the plasma cholesterol.
J. Goldstein (1984)
10.1161/STROKEAHA.108.534107
Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial by Stroke Subtypes
P. Amarenco (2009)
10.1159/000235625
Impact of Hyperlipidemia and Statins on Ischemic Stroke Outcomes after Intra-Arterial Fibrinolysis and Percutaneous Mechanical Embolectomy
L. Restrepo (2009)
10.1016/j.brainres.2015.04.025
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia
D. Carone (2015)
10.1161/01.STR.32.2.461
Very Early Nimodipine Use in Stroke (VENUS): A Randomized, Double-Blind, Placebo-Controlled Trial
J. Horn (2001)
10.1161/HYPERTENSIONAHA.112.199646
Angiotensin II Type 2 Receptor Stimulation Initiated After Stroke Causes Neuroprotection in Conscious Rats
C. McCarthy (2012)
10.1161/STROKEAHA.114.008260
&bgr;-Blockers, Pneumonia, and Outcome After Ischemic Stroke: Evidence From Virtual International Stroke Trials Archive
M. Sykora (2015)
10.1016/J.AMJHYPER.2006.04.013
Antihypertensive Drugs and Fibrinolytic Function: Impact of Dual Calcium Channel and Renin-Angiotensin System Blockade
Roberto Fogari (2006)
10.1177/0271678X15608395
Stroke neuroprotection revisited: Intra-arterial verapamil is profoundly neuroprotective in experimental acute ischemic stroke
Michael E. Maniskas (2016)
10.1007/s12035-014-8830-6
Low-Dose Candesartan Enhances Molecular Mediators of Neuroplasticity and Subsequent Functional Recovery After Ischemic Stroke in Rats
T. Ishrat (2014)
10.1056/NEJMoa0804593
Telmisartan to prevent recurrent stroke and cardiovascular events.
S. Yusuf (2008)
10.1186/s12883-015-0376-3
Effect of pre-stroke statin use on stroke severity and early functional recovery: a retrospective cohort study
J. Choi (2015)
10.1161/01.STR.0000166048.35740.a9
Morbidity and Mortality After Stroke, Eprosartan Compared With Nitrendipine for Secondary Prevention: Principal Results of a Prospective Randomized Controlled Study (MOSES)
J. Schrader (2005)
10.1186/s12883-015-0466-2
Secondary prevention after ischaemic stroke: the ASPIRE-S study
Linda M Brewer (2015)
10.1016/j.phrs.2014.06.007
Statins in neurological disorders: an overview and update.
Anna Maria Malfitano (2014)
10.1111/ijs.12471
Association between Atherogenic Dyslipidemia and Recurrent Stroke Risk in Patients with Different Subtypes of Ischemic Stroke
L. Zhao (2015)
10.1016/S0140-6736(02)08089-3
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
B. Dahlöf (2002)
10.1080/08998280.2003.11927893
Angiotensin Ii Receptor Blockers
A. Barreras (2003)
10.1517/14656566.4.5.825
ACE inhibitors versus diuretics: ALLHAT versus ANBP2
S. Doggrell (2003)
10.1007/s00115-009-2685-5
Orolinguales Angioödem unter systemischer Thrombolyse mit rt-PA
C. Ottomeyer (2009)
10.1161/CIRCULATIONAHA.109.874834
Rosuvastatin in the Prevention of Stroke Among Men and Women With Elevated Levels of C-Reactive Protein: Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER)
B. Everett (2010)
10.1111/j.1749-6632.2012.06691.x
Pathobiology of injury after stroke: the neurovascular unit and beyond.
U. Dirnagl (2012)
10.1056/NEJMOA021716
A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.
L. Wing (2003)
10.1002/jnr.490340111
Hydroxyl radical production and lipid peroxidation paralles selective post‐ischemic vulnerability in gerbil brain
Edward D. Hall (1993)
10.1161/HYPERTENSIONAHA.115.05185
Activation of the Neuroprotective Angiotensin-Converting Enzyme 2 in Rat Ischemic Stroke
Douglas M Bennion (2015)
10.7326/M14-0773
Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis.
J. Sundström (2015)
10.1172/JCI14276
Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin.
G. Nguyen (2002)
10.1001/jama.2011.1650
Level of systolic blood pressure within the normal range and risk of recurrent stroke.
B. Ovbiagele (2011)
10.1016/j.jstrokecerebrovasdis.2015.04.035
Effect of β-Adrenergic Antagonists on In-Hospital Mortality after Ischemic Stroke.
C. Phelan (2015)
10.1016/j.pharmthera.2014.09.003
Neuroprotection for ischaemic stroke: current status and challenges.
A. Moretti (2015)
10.1007/BF00966787
Synaptosomal non-mitochondrial ATPase activities and drug treatment
G. Benzi (1993)
10.1161/01.RES.87.5.E1
A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9
M. Donoghue (2000)
10.1161/01.STR.0000116869.64771.5A
Blood Pressure and Stroke: An Overview of Published Reviews
C. Lawes (2004)
10.1016/S0090-3019(97)00500-4
Tizanidine is an effective agent in the prevention of focal cerebral ischemia in rats: an experimental study.
M. Z. Berkman (1998)
10.1136/jnnp-2014-308948
Preadmission use of ACE inhibitors or angiotensin receptor blockers and short-term mortality after stroke
J. Sundbøll (2014)
10.1016/S1474-4422(09)70058-4
Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention
P. Amarenco (2009)
10.1161/STROKEAHA.114.008512
Effects of Blood Pressure–Lowering Treatment in Different Subtypes of Acute Ischemic Stroke
E. Sandset (2015)
10.1097/ANA.0b013e31827fe3b1
Quantitative Evaluation of the Neuroprotective Effects of a Short-acting &bgr;-Adrenoceptor Antagonist at a Clinical Dose on Forebrain Ischemia in Gerbils: Effects of Esmolol on Ischemic Depolarization and Histologic Outcome of Hippocampal CA1
Tetsuya Danura (2013)
10.1177/1074248410373751
Impact of Angiotensin-Converting Enzyme Inhibitors Administration Prior to Acute Ischemic Stroke Onset on In-Hospital Mortality
Y. Hassan (2010)
10.1161/STROKEAHA.112.655894
Statin Therapy and the Risk of Intracerebral Hemorrhage: A Meta-Analysis of 31 Randomized Controlled Trials
J. McKinney (2012)
10.1016/j.jstrokecerebrovasdis.2014.05.021
Hypertensive patients using thiazide diuretics as primary stroke prevention make better functional outcome after ischemic stroke.
Hong-Mo Shih (2014)
10.1161/01.ATV.0000044458.23905.3B
Treatment With Statins After Induction of Focal Ischemia in Rats Reduces the Extent of Brain Damage
L. Sironi (2003)
10.1016/S0140-6736(02)11911-8
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.
S. Lewington (2002)
10.1159/000200450
Lipid-Lowering Drugs in Ischemic Stroke Prevention and Their Influence on Acute Stroke Outcome
B. Fuentes (2009)
10.1161/STROKEAHA.112.668277
Statin Therapy and Outcome After Ischemic Stroke: Systematic Review and Meta-Analysis of Observational Studies and Randomized Trials
D. Ní Chróinín (2013)
10.1177/1074248410369110
Effects of Statins on Progression of Carotid Atherosclerosis as Measured By Carotid Intimal—Medial Thickness: A Meta-Analysis of Randomized Controlled Trials
U. Bedi (2010)
10.1136/jnnp-2014-307856
Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial
H. Arima (2014)
10.1097/00005344-199810000-00014
ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients.
R. Fogari (1998)
Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack
S. MacMahon (2001)
10.1016/j.atherosclerosis.2012.04.017
Beta-blockers use and risk of hyperglycemia in acute stroke patients.
T. Dziedzic (2012)
Statins excert neuroprotection on cerebral ischemia independent of their lipid-lowering action: the potential molecular mechanisms.
Q. Li (2014)
10.1001/ARCHINTE.160.2.211
Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertension in China (Syst-China) Collaborative Group.
J. Wang (2000)
10.1227/00006123-198602000-00003
Improved neurological outcome in experimental focal cerebral ischemia treated with propranolol.
M. Standefer (1986)
10.1097/00006123-198501000-00005
Treatment of acute focal cerebral ischemia and recirculation with d-propranolol.
J. Latchaw (1985)
10.1177/1753944715599875
Angiotensin-(1–7): beyond its central effects on blood pressure
M. Gironacci (2015)
10.1111/jnc.12719
Brain proteomics identifies potential simvastatin targets in acute phase of stroke in a rat embolic model
Mireia Campos-Martorell (2014)
10.1371/journal.pone.0084389
Association between Statin Use and Short-Term Outcome Based on Severity of Ischemic Stroke: A Cohort Study
B. Song (2014)
10.1136/bmj.296.6624.737
Low dose β blockade in acute stroke (“BEST” trial): an evaluation
D. Barer (1988)
10.1038/hr.2013.100
Effects of a benidipine-based combination therapy on the risk of stroke according to stroke subtype: the COPE trial
S. Umemoto (2013)
10.1136/jnnp-2014-308097
Incidence, predictors and clinical characteristics of orolingual angio-oedema complicating thrombolysis with tissue plasminogen activator for ischaemic stroke
R. Hurford (2014)
10.1056/NEJM198904063201405
Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial.
H. Iso (1989)
10.1111/bph.13285
Early treatment with atorvastatin exerts parenchymal and vascular protective effects in experimental cerebral ischaemia
C. Potey (2015)
10.1016/j.amjopharm.2012.09.001
The effect of statins on acute and long-term outcome after ischemic stroke in the elderly.
C. Hjalmarsson (2012)
10.1016/j.brainres.2009.09.064
The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor simvastatin reduces thrombolytic-induced intracerebral hemorrhage in embolized rabbits
P. Lapchak (2009)
10.1007/s11936-012-0174-9
Neuroprotective Effects of Statins: Evidence from Preclinical and Clinical Studies
M. Fisher (2012)
10.1161/01.STR.25.2.333
Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project.
J. Burn (1994)
10.1093/oxfordjournals.bmb.a072892
Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease.
R. Collins (1994)
10.1016/j.neuroscience.2004.02.011
Clonidine preconditioning decreases infarct size and improves neurological outcome from transient forebrain ischemia in the rat
Y. Zhang (2004)
10.1161/STROKEAHA.111.000001
Should Statins Be Paused or Discontinued After Thrombolysis or Acute Intracerebral Hemorrhage? No!
J. Scheitz (2013)
10.1161/STROKEAHA.111.648832
High-dose statin for every stroke: the good, the bad, and the unknown.
M. Selim (2012)
10.1212/CPJ.0b013e318296f0a9
Contraindications to intravenous rtPA for acute stroke: A critical reappraisal.
J. Fugate (2013)
10.1212/WNL.0b013e3182918d38
Treatment with statins and ischemic stroke severity
P. Martínez-Sánchez (2013)
10.1097/HJH.0000000000000364
Compound 21 is pro-angiogenic in the brain and results in sustained recovery after ischemic stroke
A. Alhusban (2015)
Post-stroke antihypertensive treatment study. A preliminary result
Pats-Collaborating-Group- (1995)
10.1161/CIRCULATIONAHA.112.145334
Statins as Antithrombotic Drugs
F. Violi (2013)
10.1007/s12028-013-9863-9
A Prospective Evaluation of Labetalol Versus Nicardipine for Blood Pressure Management in Patients with Acute Stroke
Xi Liu-Deryke (2013)
10.1016/J.PHARMTHERA.2006.09.003
Prevention of stroke and dementia by statin therapy: experimental and clinical evidence of their pleiotropic effects.
T. Miida (2007)
10.1186/1741-7015-2-4
Rising statin use and effect on ischemic stroke outcome
S. Yoon (2004)
10.1016/j.brainres.2012.04.040
Neuroprotective effects of selective beta-1 adrenoceptor antagonists, landiolol and esmolol, on transient forebrain ischemia in rats; a dose–response study
Toru Goyagi (2012)
10.1111/joim.12387
Treatment of acute stroke: an update
R. Mikulik (2015)
10.1001/ARCHNEUR.1996.00550040031011
Lipids and stroke: a paradox resolved.
V. Hachinski (1996)
10.1096/fj.04-2960fje
Angiotensin AT2 receptor protects against cerebral ischemia‐induced neuronal injury
J. Li (2005)
10.1073/pnas.1432869100
Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas
R. Santos (2003)
10.1007/S11883-009-0045-3
Statins and ischemic stroke severity: Cytoprotection
Larry B Goldstein (2009)
10.1007/s12028-010-9376-8
Na+–K+–2Cl− Cotransport Inhibitor Attenuates Cerebral Edema Following Experimental Stroke via the Perivascular Pool of Aquaporin-4
Elton Rodrigues Migliati (2010)
10.1038/hr.2009.139
Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature
L. Liu (2009)
10.1016/j.jstrokecerebrovasdis.2009.08.006
Renin-angiotensin system blockade safely reduces blood pressure in patients with minor ischemic stroke during the acute phase.
T. Nakamura (2010)
10.1042/CS20130324
Cerebroprotective action of angiotensin peptides in stroke.
Robert W Regenhardt (2014)
10.1212/01.wnl.0000261914.18101.60
Is prestroke use of angiotensin-converting enzyme inhibitors associated with better outcome?
N. Chitravas (2007)
10.1016/J.JACC.2007.01.083
Low-density lipoprotein-dependent and -independent effects of cholesterol-lowering therapies on C-reactive protein: a meta-analysis.
S. Kinlay (2007)
10.1159/000069498
Effects of Blood Pressure Lowering in the Acute Phase of Total Anterior Circulation Infarcts and Other Stroke Subtypes
N. Ahmed (2003)
10.1111/j.1552-6569.2006.00061.x
Statin Use is Independently Associated with Smaller Infarct Volume in Nonlacunar MCA Territory Stroke
S. Shook (2006)
10.1212/01.wnl.0000269789.09277.47
Statin treatment withdrawal in ischemic stroke
M. Blanco (2007)
10.1097/ANA.0b013e31820369c1
Neuroprotective Effects and Suppression of Ischemia-induced Glutamate Elevation by &bgr;1-Adrenoreceptor Antagonists Administered Before Transient Focal Ischemia in Rats
T. Goyagi (2011)
10.1161/HC0402.102929
Fosinopril Versus Amlodipine Comparative Treatments Study: A Randomized Trial to Assess Effects on Plasminogen Activator Inhibitor-1
M. Pahor (2002)
10.1161/STROKEAHA.111.633339
High-dose statins should only be used in atherosclerotic strokes.
Karen L. Furie (2012)
10.1212/WNL.0b013e3182575142
Inpatient statin use predicts improved ischemic stroke discharge disposition
A. Flint (2012)
10.3892/ijmm.2013.1583
Long-term prehypertension treatment with losartan effectively prevents brain damage and stroke in stroke-prone spontaneously hypertensive rats
De-Hua He (2014)
10.1503/cmaj.150624
Risk of ischemic stroke during the initiation period of α-blocker therapy among older men
Chao-Lun Lai (2015)
Blood pressure and stroke.
J. Evans (1988)
10.1111/ijs.12604
Intravenous Thrombolysis and Intra-Arterial Interventions in Acute Ischemic Stroke: Italian Stroke Organisation (ISO)-Spread Guidelines
D. Toni (2015)
10.1371/journal.pone.0095762
Direct Angiotensin AT2 Receptor Stimulation Using a Novel AT2 Receptor Agonist, Compound 21, Evokes Neuroprotection in Conscious Hypertensive Rats
C. McCarthy (2014)
10.1586/erc.13.42
The impact of ACE inhibition on all-cause and cardiovascular mortality in contemporary hypertension trials: a review
R. Ferrari (2013)
10.1016/j.neuropharm.2011.01.003
Acute lipophilicity-dependent effect of intravascular simvastatin in the early phase of focal cerebral ischemia
S. Beretta (2011)
10.1007/s00115-009-2685-5
[Orolingual angioedema under systemic thrombolysis with rt-PA: an underestimated side effect].
C. Ottomeyer (2009)
10.1038/hr.2011.51
Nifedipine treatment reduces brain damage after transient focal ischemia, possibly through its antioxidative effects
M. Yamato (2011)
10.1159/000140095
The Effect of Statin Pretreatment on Infarct Volume in Ischemic Stroke
J. Nicholas (2008)
10.1097/00004872-200109000-00001
Why are strokes related to hypertension? Classic studies and hypotheses revisited.
C. Dickinson (2001)
10.1111/j.1468-1331.2008.02370.x
The beneficial effect of statins treatment by stroke subtype
P. Martínez-Sánchez (2009)
10.1097/01.hjh.0000160223.94220.29
Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial
J. Lubsen (2005)
Action of piracetam and clonidine on different mitochondrial populations from hippocampus.
R. Villa (1989)
10.1016/S0140-6736(04)15690-0
Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.
R. Collins (2004)
10.1007/s11906-014-0512-2
Neuroprotective Mechanisms of the ACE2–Angiotensin-(1-7)–Mas Axis in Stroke
Douglas M Bennion (2015)
10.2174/1874467208666150507105845
Pharmacology of L-type Calcium Channels: Novel Drugs for Old Targets?
J. Striessnig (2015)
10.1016/bs.apha.2014.06.013
Drug delivery to the ischemic brain.
B. J. Thompson (2014)
10.1161/STROKEAHA.111.648576
Telmisartan on Top of Antihypertensive Treatment Does Not Prevent Progression of Cerebral White Matter Lesions in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) MRI Substudy
R. Weber (2012)
10.1161/STROKEAHA.113.001022
Effects of Candesartan in Acute Stroke on Cognitive Function and Quality of Life: Results From the Scandinavian Candesartan Acute Stroke Trial
A. G. Hornslien (2013)
10.5853/jos.2015.17.3.282
Statins in Acute Ischemic Stroke: A Systematic Review
K. Hong (2015)
10.1016/S0140-6736(11)60104-9
The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial
E. Sandset (2011)
10.1124/mol.109.054544
Genetic Dissection of α2-Adrenoceptor Functions in Adrenergic versus Nonadrenergic Cells
R. Gilsbach (2009)
10.1007/s00234-007-0273-6
MRI at 3 Tesla detects no evidence for ischemic brain damage in intensively treated patients with homozygous familial hypercholesterolemia
S. A. Schmitz (2007)
10.1111/j.1600-0404.2009.01299.x
Effect of cilnidipine vs losartan on cerebral blood flow in hypertensive patients with a history of ischemic stroke: a randomized controlled trial
K. Hong (2010)
10.1161/STROKEAHA.107.487090
Risk Factors for Intracerebral Hemorrhage in a Pooled Prospective Study
J. D. Sturgeon (2007)
10.1097/TA.0b013e31819388be
The in vivo effect of propranolol on cerebral perfusion and hypoxia after traumatic brain injury.
E. Ley (2009)
10.1185/03007995.2014.964855
Effects of lercanidipine versus amlodipine in hypertensive patients with cerebral ischemic stroke.
Thuc Sinh Cao (2015)
10.1177/1073858406297121
Statins: Multiple Mechanisms of Action in the Ischemic Brain
Mauro Cimino (2007)
10.1212/WNL.0b013e31822c9135
IV thrombolysis and statins
S. Engelter (2011)
10.1016/j.cmet.2015.05.022
HMG-CoA Reductase Inhibitors Bind to PPARα to Upregulate Neurotrophin Expression in the Brain and Improve Memory in Mice.
Avik Roy (2015)
10.1038/sj.jcbfm.9600116
Statins and Stroke
M. Endres (2005)
10.1097/HJH.0b013e328348345d
Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: a randomized controlled trial
M. Matsuzaki (2011)
10.1002/jnr.23532
Different protective and reparative effects of olmesartan in stroke according to time of administration and withdrawal
M. Gutiérrez-Fernández (2015)
10.1161/STROKEAHA.114.005982
Response of Day-to-Day Home Blood Pressure Variability by Antihypertensive Drug Class After Transient Ischemic Attack or Nondisabling Stroke
A. Webb (2014)
10.1016/j.atherosclerosis.2015.09.026
Alpha1beta1 and integrin-linked kinase interact and modulate angiotensin II effects in vascular smooth muscle cells.
J. Moraes (2015)
10.1001/JAMA.288.23.3039
The verdict from ALLHAT--thiazide diuretics are the preferred initial therapy for hypertension.
L. Appel (2002)
10.1016/j.jstrokecerebrovasdis.2010.09.011
Benefits of prestroke use of angiotensin type 1 receptor blockers on ischemic stroke severity.
N. Miyamoto (2012)
Pre-stroke use of statins on stroke outcome: a meta-analysis of observational studies.
A. Cordenier (2011)
10.1097/00004872-200305000-00011
The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial
H. Lithell (2003)
10.1155/2014/873590
Inhibition of Brain Swelling after Ischemia-Reperfusion by β-Adrenergic Antagonists: Correlation with Increased K+ and Decreased Ca2+ Concentrations in Extracellular Fluid
D. Song (2014)
10.1161/STROKEAHA.107.501700
Effect of Pretreatment With Statins on Ischemic Stroke Outcomes
M. Reeves (2008)
10.1002/14651858.CD007890.pub3
Beta-blockers for preventing stroke recurrence.
Luiz Gustavo De Lima (2014)
10.3109/10641963.2011.577491
Effects of Lisinopril, Irbesartan, and Amlodipine on the Thrombogenic Variables in the Early and Late Stages of the Treatment in Hypertensive Patients
Ozlem Tiryaki (2012)
10.1161/STROKEAHA.107.487017
Discontinuation of Statin Therapy and Clinical Outcome After Ischemic Stroke
Furio Colivicchi (2007)
10.1161/STROKEAHA.108.532473
Prior statin use, intracranial hemorrhage, and outcome after intra-arterial thrombolysis for acute ischemic stroke.
N. Meier (2009)
Angiotensin II via AT1 receptor accelerates arterial thrombosis in renovascular hypertensive rats.
M. Kamińska (2005)
10.1016/S0140-6736(07)61778-4
Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths.
S. Lewington (2007)
10.1007/s12028-010-9465-8
Cerebral Hemodynamic and Metabolic Effects of Equi-Osmolar Doses Mannitol and 23.4% Saline in Patients with Edema Following Large Ischemic Stroke
M. Diringer (2011)
10.2174/15701611113119990134
Statin treatment and carotid plaque composition: a review of clinical studies.
M. Puato (2014)
10.1111/1755-5922.12138
Calcium-Channel Blockers Attenuate the Antiplatelet Effect of Clopidogrel.
T. Gremmel (2015)
10.1097/00004647-200106000-00009
Na+-K+-Cl− Cotransporter in Rat Focal Cerebral Ischemia
Y. Yan (2001)
10.1016/j.thromres.2015.12.008
The acute prothrombotic effect of aldosterone in rats is partially mediated via angiotensin II receptor type 1.
A. Gromotowicz-Popławska (2016)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar